February 2026
Morikol® Marine Collagen – Clinically proven, low-dose, formulation-ready
ACI Group, in partnership with DolCas Biotech, supplies Morikol®, a clinically proven marine collagen hydrolysate enriched in tripeptides, to UK formulators and manufacturers. Morikol® delivers precision, efficacy, and convenience for modern wellness formulations.
Key Benefits:
Clinically proven efficacy at ultra-low doses (1–2g/day)
Clean-label, traceable, and sustainable sourcing
Flexible formulation options across food, beverage, and nutraceutical products
High concentration of Gly-Pro-Hyp (GPH) tripeptides for skin, joint, and connective tissue health
Formats include (but not limited to): capsules, powders, RTDs, gummies, bars, stick packs, and chocolate applications.
Precision over volume: Low-dose, high-impact collagen
Traditional collagen supplements often require 5–15g per serving to see visible results. Morikol® challenges the high-dose approach, using scientifically validated bioactive tripeptides to deliver measurable results at fraction of the dose.
Clinical highlights:
| Benefit Area | Dose | Outcome |
|---|---|---|
| Skin Hydration & Elasticity | 1g/day | Noticeable improvement in 6 weeks; 10.5× greater wrinkle reduction vs placebo at 12 weeks |
| Joint Comfort & Mobility | 2g/day | Reduced stiffness, improved flexibility, and range of motion over 10 weeks |
How it works:
Low molecular weight (~300 Da) tripeptides, of which Morikol® is enriched, are absorbed directly into the bloodstream
Stimulates collagen synthesis, hyaluronic acid, and ceramide production
Enables smaller serving sizes, simplified SKUs, and consumer-friendly formulations
Why Marine Collagen is the future
Morikol® delivers a clean, high-performance marine collagen solution:
Superior bioavailability - faster, more efficient absorption than standard hydrolysed collagen
Clean-label credentials - non-GMO, halal & kosher certified, Prop 65 compliant
Sustainable sourcing - traceable, environmentally conscious fish-derived collagen
Low-dose efficiency - ideal for capsules, powders, RTDs, gummies, bars, and more
Marine collagen is projected to grow at a CAGR of 7% through 2030, positioning it as a premium, future-proof ingredient for wellness, beauty, and functional products.
Formulation advantages:
Neutral taste and solubility - disperses evenly in hot or cold liquids without gritty texture
Low-dose, high-impact - 1–2g/day efficacy reduces ingredient costs and simplifies SKUs
Formula stability - high batch-to-batch consistency ensures compatibility with vitamins, minerals, and antioxidants
ACI Group - Your UK partner in Collagen innovation
ACI Group brings technical expertise, market insight, and clinical credibility to UK formulators. With Morikol®, brands gain:
Clinically validated, low-dose marine collagen
High bioavailability and tissue-targeted absorption
Flexibility for all delivery formats
Sustainable, traceable, and clean-label ingredient support
Pull quote: “As the global collagen market approaches $8bn by 2030, Morikol® represents a strategic, science-backed opportunity for forward-thinking brands,” – Karsten Smet, CEO, ACI Group
Contact our expertsWhy Morikol® is different
Clinically validated: Proven outcomes at 1–2g/day
Precision tripeptides: Gly-Pro-Hyp sequence maximizes collagen synthesis
Formulation flexibility: Capsules, powders, gummies, bars, RTDs, chocolates
Sustainable marine source: Traceable, ethical, and clean-label
Easy absorption: Rapid uptake for skin, joint, and connective tissue health